Department of Nuclear Medicine, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, China.
The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Laboratory for Neuroinformation, High-Field Magnetic Resonance Brain Imaging Key Laboratory of Sichuan Province, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Eur Radiol. 2024 Feb;34(2):887-898. doi: 10.1007/s00330-023-10089-1. Epub 2023 Aug 15.
To investigate [F]FDG PET patterns of mesial temporal lobe epilepsy (MTLE) patients with distinct pathologic types and provide possible guidance for predicting long-term prognoses of patients undergoing epilepsy surgery.
This was a retrospective review of MTLE patients who underwent anterior temporal lobectomy between 2016 and 2021. Patients were classified as having chronic inflammation and gliosis (gliosis, n = 44), hippocampal sclerosis (HS, n = 43), or focal cortical dysplasia plus HS (FCD-HS, n = 13) based on the postoperative pathological diagnosis. Metabolic patterns and the severity of metabolic abnormalities were investigated among MTLE patients and healthy controls (HCs). The standardized uptake value (SUV), SUV ratio (SUVr), and asymmetry index (AI) of regions of interest were applied to evaluate the severity of metabolic abnormalities. Imaging processing was performed with statistical parametric mapping (SPM12).
With a mean follow-up of 2.8 years, the seizure freedom (Engel class IA) rates of gliosis, HS, and FCD-HS were 54.55%, 62.79%, and 69.23%, respectively. The patients in the gliosis group presented a metabolic pattern with a larger involvement of extratemporal areas, including the ipsilateral insula. SUV, SUVr, and AI in ROIs were decreased for patients in all three MTLE groups compared with those of HCs, but the differences among all three MTLE groups were not significant.
MTLE patients with isolated gliosis had the worst prognosis and hypometabolism in the insula, but the degree of metabolic decrease did not differ from the other two groups. Hypometabolic regions should be prioritized for [F]FDG PET presurgical evaluation rather than [F]FDG uptake values.
This study proposes guidance for optimizing the operation scheme in patients with refractory MTLE and emphasizes the potential of molecular neuroimaging with PET using selected tracers to predict the postsurgical histology of patients with refractory MTLE epilepsy.
• MTLE patients with gliosis had poor surgical outcomes and showed a distinct pattern of decreased metabolism in the ipsilateral insula. • In the preoperative assessment of MTLE, it is recommended to prioritize the evaluation of glucose hypometabolism areas over [F]FDG uptake values. • The degree of glucose hypometabolism in the epileptogenic focus was not associated with the surgical outcomes of MTLE.
研究不同病理类型的内侧颞叶癫痫(MTLE)患者的[F]FDG PET 模式,为预测癫痫手术患者的长期预后提供可能的指导。
这是一项回顾性研究,纳入了 2016 年至 2021 年间接受前颞叶切除术的 MTLE 患者。根据术后病理诊断,将患者分为慢性炎症和神经胶质增生(神经胶质增生,n=44)、海马硬化(HS,n=43)或局灶性皮质发育不良伴 HS(FCD-HS,n=13)。在 MTLE 患者和健康对照者(HCs)中研究代谢模式和代谢异常严重程度。应用感兴趣区的标准化摄取值(SUV)、SUV 比值(SUVr)和不对称指数(AI)评估代谢异常的严重程度。采用统计参数映射(SPM12)进行成像处理。
平均随访 2.8 年后,神经胶质增生、HS 和 FCD-HS 组的癫痫无发作(Engel 分级 IA)率分别为 54.55%、62.79%和 69.23%。神经胶质增生组患者表现出代谢模式,涉及颞外区域(包括同侧岛叶)更大。与 HCs 相比,所有 3 个 MTLE 组患者的 ROI 中 SUV、SUVr 和 AI 均降低,但 3 组之间差异无统计学意义。
孤立性神经胶质增生的 MTLE 患者预后最差,岛叶代谢降低,但降低程度与其他两组无差异。在 [F]FDG PET 术前评估中,应优先考虑代谢降低区域,而不是 [F]FDG 摄取值。
本研究为药物难治性 MTLE 患者优化手术方案提供了指导,并强调了使用特定示踪剂的 PET 分子神经影像学在预测药物难治性 MTLE 癫痫患者术后组织学方面的潜在价值。
神经胶质增生的 MTLE 患者手术效果差,表现为同侧岛叶代谢明显降低。
在 MTLE 的术前评估中,建议优先评估葡萄糖代谢低下区域,而不是 [F]FDG 摄取值。
致痫灶的葡萄糖代谢低下程度与 MTLE 的手术结果无关。